Title for MeetingAbstracts
Alphabetical listing of titles
Phase II Clinical Trial of Daclizumab/Amphotericin B Combination.
Phase II clinical trial of liposomal daunorubicin in the treatment of pulmonary Kaposi's sarcoma.
Phase II clinical trials of delavirdine mesylate combination therapy.
Phase II clinical trials of novel differentiation inducer--antineoplaston AS2-1 in AIDS and asymptomatic HIV infection.
Phase II microbicide trial participants' opinions about phase III trial methodology.
Phase II study of alpha 2A interferon (INF) associated with AZT in patients (pts) with AIDS related Kaposi's sarcoma.
Phase II study of combination of lentinan with ddI in HIV-positive patients.
Phase II study of liposomal daunorubicin (DaunoXome) in AIDS related Kaposi sarcoma.
Phase II study of R 18893 (TIBO-like compound) in 15 patients with AIDS.
Phase II study of ritonavir-nelfinavir combination therapy: an update.
Phase II Study of the Safety and Efficacy of Nebulized Zanamivir in Patients with Serious Influenza Virus Infections.
Phase II Trial liposomal daunorubicin with concurrent protease inhibitors in AIDS-related kaposi's Saracoma.
Phase II trial of alternating and intermittent regimens of zidovudine (ZDV) and 2',3'-dideoxycytidine (ddC) in ARC and AIDS.
Phase II trial of CPI-1189 for HIV-associated motor cognitive impairment.
Phase II trial of HIV-1 subtype E and B gp120 vaccines in Seronegative Thai adults.
Phase II, Randomized, Open Label Study of Two Intravenous Dosing Regimens of V-Echinocandin in the Treatment of Esophageal Candidiasis.
Phase II: attending injecting drug users (IDUs)--creating a "setting".
Phase III international study of valaciclovir (VACV) for cytomegalovirus (CMV) prophylaxis in patients with advanced HIV disease.
Phase III recombinant GM-CSF (rGM-CSF) and ganciclovir (GCV) in neutropenic AIDS patients with CMV retinitis.
Phase III trial of antibiotics to reduce chorioamnionitis-associated MTCT of HIV.
Phase III trial of HIV prime-boost vaccine combination in Thailand.
PHASE IV CLINICAL TRIAL TO ACCESS THE EFFICACY AND SAFETY OF ANTIRETROVIRAL TREATMENT WITH RITONAVIR AND SAQUINAVIR (400 mg-400 mg) CONCOMITANT WITH RIFAMPICIN IN TUBERCULOSIS AND AIDS PATIENTS.
Phase one study of the safety and tolerability of nonoxynol-9: histological evidence of an inflammatory response.
Phase-1 study of recombinant peptide corresponding to the GP41 transmembrane protein of the HIV-1 virus coupled to Ficoll.
Phase-I study of A-77003, a HIV protease inhibitor, in man.
Phase-I study of liposomal-azidothymidine (AZT) in advanced HIV disease.
Phase-I Study with a Therapeutic MVA-BN-Nef Vaccine in HIV-1 Infected Patients on HAART.
Phase-I trial of pegylated recombinant human megakaryocyte growth and development factor for HIV-associated thrombocytopenia.
Phase-I-study with a MVA-BN-Nef vaccine in HIV-1 negative volunteers.
Phases of SIV infection in rhesus macaques: role of lymphoid organs in pathogenesis.